Aarskog-Scott syndrome is a rare disease that results in developmental abnormalities in the body, such as shortened stature, abnormal facial features, and limb and genital abnormalities. This rare disease is caused by a genetic mutation in the FGD1 gene, which is responsible for turning on expression of proteins that are important for bone growth and development in different areas of the body. Aarskog-Scott syndrome (AAS) symptoms are more often expressed in people who are born genetically male, and it is these characteristic features that aid in diagnosing this rare disease. Some individuals with AAS may experience delayed or decreased cognitive development, but this is not a common symptom of this disorder.
Aarskog-Scott syndrome is a rare disease that results in developmental abnormalities in the body, such as shortened stature, abnormal facial features, and limb and genital abnormalities. This rare disease is caused by a genetic mutation in the FGD1 gene, which is responsible for turning on expression of proteins that are important for bone growth and development in different areas of the body. Aarskog-Scott syndrome (AAS) symptoms are more often expressed in people who are born genetically male, and it is these characteristic features that aid in diagnosing this rare disease. Some individuals with AAS may experience delayed or decreased cognitive development, but this is not a common symptom of this disorder.
Aarskog-Scott syndrome is a rare disease estimated to occur in about 1 in 25,000 people. However, this is considered a low estimation due to the wide range of physical characteristics that people with this syndrome express, and thus difficulty in identifying cases for genetic diagnosis. AAS is more common in people assigned male at birth than female. About 60 cases of AAS have been identified based on the presence of a FGD1 genetic mutation.
Name | Abbreviation |
---|---|
Aarskog Disease | AD |
Faciodigitogenital syndrome | |
Faciogenital dysplasia | FGDY |
About 22% of total cases of Aarskog-Scott syndrome are caused by an X-linked genetic disease caused by a mutation in the FGD1 gene. There are no other known causes of AAS at this time, probably due to lack of genetic testing for a majority of diagnosed cases.
Humans have 23 pairs of chromosomes, with one of each pair inherited from both parents at birth. The 23rd chromosome pair is called the sex chromosome, because they vary depending on the assigned sex of the baby at birth. People assigned male at birth have an X chromosome from their mother and a Y chromosome from their father, while people assigned female at birth have two X chromosomes from their mother and father (the names indicate the shape of the chromosomes). Sex-linked genetic disorders can arise when a mutation is present on one chromosome, often the X chromosome, without a normal copy present on a matching chromosome. Thus, males express the mutant form of the gene only, while females carry the mutant form in one X chromosome but often express the non-mutant form contributed by the other X chromosome.
The FGD1 gene stands for faciogenital dysplasia 1 gene, which encodes a protein that acts as an activator for another gene, Cdc42. This gene encodes a protein that is responsible for signaling different development events to take place in the body, in particular bone development. Without a fully functional gene for FGD1, this process of development cannot properly begin, and thus developmental abnormalities appear that are characteristic of Aarskog-Scott syndrome.
Aarskog-Scott syndrome is a rare disease that causes a form of skeletal dysplasia, meaning abnormal development of certain parts of the body due to genetic mutations affecting the bones. This disorder often occurs in people assigned male at birth, and while there are many features that vary from person to person, there are distinct characteristics that can be used to determine an Aarskog-Scott syndrome diagnosis:
Facial features: rounded face, broad forehead, wide space between the eyes (ocular hypertelorism), drooping eyelids, smaller nose with outward flared nostrils (anteverted nares), underdeveloped jaw bone (maxilliary hypoplasia), widow’s peak, long upper lip, broadened bridge of the nose
Less common: eye abnormalities such as crossed eyes, farsightedness, paralysis of certain muscles in the eye
Ear features: low-set ears, thick and fleshy earlobes
Dental features: missing teeth at birth, delayed growth of teeth, underdevelopment of enamel around the outside of the tooth (enamel hypoplasia)
Less common: incomplete closure of the roof of the mouth or upper lip (cleft palate or lip)
Stature features: shortened height, broad and short hands and feet, short and stubby fingers (brachydactyly), permanently bent pinky finger (clinodactyly), highly extendible finger joints, wide and flat feet with larger toes
Midsection features: sunken chest, protruding belly and navel due to large intestine invading into abnormal opening in the abdominal muscular lining, incomplete closure of the bones of the spinal column (spina bifida occulta), fusion of upper bones in spinal column (cervical vertebrae)
Genital features: abnormal fold of skin at the base of the penis, failure of one or both testes to descend (cryptorchidism), urinary opening located on the underside of the penis
Behavior and learning disorders have been described in some individuals with Aarskog-Scott syndrome, but it is not a consistent feature. Children assigned male at birth with the disorder may present as hyperactive, attention deficit, and impulsive, common symptoms of ADHD.
Other complications that can result from Aarskog-Scott syndrome developmental abnormalities can include failure to gain weight and grow at expected rate, congenital heart defects, and abnormal curvature of the spine (scoliosis).
The physical abnormalities or developmental differences associated with Aarskog-Scott syndrome are often the first sign to seek diagnosis of this rare disease. The characteristic features, combined with genetic and family history, provide sufficient information to diagnose Aarskog-Scott syndrome.
To confirm a diagnosis of Aaskarg-Scott syndrome, a genetic test to confirm a mutated gene must be conducted. If an individual has characteristic physical traits of AAS, a mutation in the FGD1 gene confirms that they have Aaskarg-Scott syndrome. If they don’t have a mutation in this gene, other genes may be tested for a mutation as they are associated with similar physical traits: ROR2, WNT5A, PIK3R1, SRCAP, KMT2D, KDM6A, SHOX, CUL7.
Treatment options for young children, often assigned male at birth, with Aarskog-Scott syndrome often depend on the symptoms experienced by the individual. It is recommended to consult with pediatricians and specialists to treat and/or correct certain physical features that may cause difficulties. This includes testing of hearing and vision to prevent certain facial abnormalities from impairing these abilities. Surgery may be recommended in certain extreme cases of structural abnormalities that lower quality of life. Treatments with growth hormones have been shown to improve height increase in some children with Aarskog-syndrome. It is also common for individuals with AAS to grow to a more average height during puberty.
While development milestones may be delayed and physical features may be abnormal, many individuals with Aarskog-Scott syndrome live healthy lives. Some may experience intellectual disabilities, but this is not a common symptom of this rare disease. Still others may experience complications due to their abnormal bone development, and should be regularly monitored by a doctor to ensure healthy growth. Due to genitalia abnormalities, some people assigned male at birth may experience fertility problems.
Jones KL, ed. Smith’s Recognizable Patterns of Human Malformation. 5th ed. Philadelphia, PA: W. B. Saunders Co.;1997:128-29.
Orrico A, Galli L, Clayton-Smith J and Fryns J-P: Clinical utility gene card for: Aarskog–Scott Syndrome (faciogenital dysplasia) – update 2015. Eur J Hum Genet. 2015 Apr; 23(4).
https://www.news-medical.net/health/Aarskog-Syndrome-Causes-and-Diagnosis.aspx
https://medlineplus.gov/genetics/condition/aarskog-scott-syndrome/
https://www.mountsinai.org/health-library/diseases-conditions/aarskog-syndrome
There are no new discussions. Start one now!!
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
There are no new discussions. Start one now!!
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITYOur rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.